We provide evidence demonstrating that CCDC86 modulates the activity of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway, a crucial signaling cascade implicated in glioma progression.22 Here, WNK2 is linked to central nervous system cancer.